Dr. Dayao ZHAO has served as biopharmaceutical leadership for more than 25 years, and currently serves as the CEO and Director of AffaMed Therapeutics, and prior to that CEO of Eucure Pharmaceuticals, where he built a first-in-class clinical development team that implemented programs worldwide.